Predictive value of artificial intelligence-based quantitative CT feature analysis for diagnosing the pathological types of pulmonary nodules [0.03%]
基于人工智能的定量CT特征分析预测肺结节病理类型的诊断价值
Haoyuan Zhang,Kun Liu,Yadong Ding et al.
Haoyuan Zhang et al.
Objectives: Accurate preoperative classification of pulmonary nodules (PNs) is critical for guiding clinical decision-making and preventing overtreatment. This study aims to evaluate the predictive performance of artifici...
Diagnostic performance of a coronary CT angiography-based deep learning model for the prediction of vessel-specific ischemia [0.03%]
基于冠状动脉CT造影的深度学习模型诊断性能预测节段缺血准确性
Benjamin Peters,Rolf Symons,Sanad Oulkadi et al.
Benjamin Peters et al.
Objectives: Fractional flow reserve (FFR) and instantaneous wave-Free Ratio (iFR) pressure measurements during invasive coronary angiography (ICA) are the gold standard for assessing vessel-specific ischemia. Artificial i...
LI-RADS nonradiation treatment response assessment version 2024: diagnostic performance in HCC treated with transarterial chemoembolization [0.03%]
LI-RADS非手术治疗反应评估2024版：经动脉化疗栓塞治疗肝细胞癌的诊断性能
Di Wang,Rong Lyu,Yang Zhang et al.
Di Wang et al.
Background and objectives: The 2024 version of the Liver Imaging Reporting and Data System (LI-RADS) Treatment Response Assessment (TRA) introduces two distinct algorithms: nonradiation TRA and radiation TRA. We aimed to ...
VIBESegmentator: full body MRI segmentation for the NAKO and UK Biobank [0.03%]
VIBESegmentator：用于NAKO和UK生物库的全身MRI分割
Robert Graf,Paul Platzek,Evamaria Olga Riedel et al.
Robert Graf et al.
Objectives: To present a publicly available deep learning-based torso segmentation model that provides comprehensive voxel-wise coverage, including delineations that extend to the boundaries of anatomical compartments. ...
Detection of macrotrabecular-massive hepatocellular carcinoma based on viscoelastic characteristics obtained by multifrequency magnetic-resonance elastography [0.03%]
基于多频磁共振弹性成像的粘弹性特征检测巨块型肝细胞癌
Zhen Wang,Qi Liang,Jia Luo et al.
Zhen Wang et al.
Objectives: To investigate the use of viscoelastic characteristics obtained with magnetic-resonance elastography (MRE) in identifying the macrotrabecular-massive (MTM) subtype of hepatocellular carcinoma (HCC) and its ass...
Navigating the CT wave: multicentric chest imaging trends before, during, and after COVID-19 Pandemic [0.03%]
新冠肺炎疫情前后胸部影像多中心趋势分析：穿越CT浪潮
Thiago Lima,Natalia Saltybaeva,Tobias Gassenmaier et al.
Thiago Lima et al.
Objective: The COVID-19 pandemic has significantly impacted healthcare practices worldwide, including the use of computed tomography (CT) in chest examinations. This study aims to analyse the trends in CT chest examinatio...
Safe for kids? AI medical devices in radiology overlook paediatric suitability [0.03%]
适合儿童吗？放射学中的AI医疗器械忽视儿科适用性问题
Brendan S Kelly,Jennifer Lee,Edward Antram et al.
Brendan S Kelly et al.
Objectives: Prior publications have highlighted inconsistent labelling of intended use cases and target population for U.S. Food and Drug Administration-approved AI medical devices, especially for children. The extent to ...
Artificial intelligence for breast cancer prevention: the vision ahead [0.03%]
人工智能在乳腺癌预防中的应用：展望前方愿景
Francesco Sardanelli,Gianfranco Scaperrotta
Francesco Sardanelli
Over the past decade, artificial intelligence (AI) has entered the medical field, particularly in radiology. Fifty years after the transition from "silver to silicon", we are experiencing a second digital revolution fueled by AI and radiomi...
Toward personalized hepatocellular carcinoma treatment using liver MRI: predicting intratumoral tertiary lymphoid structure maturity [0.03%]
基于肝脏MRI的肝细胞癌个性化治疗研究：预测瘤内三级淋巴组织成熟度
Dong Ho Lee,Jeong Min Lee
Dong Ho Lee
Predicting early progression to atezolizumab-bevacizumab in hepatocellular carcinoma: a clinical and imaging-based scoring system [0.03%]
预测肝细胞癌患者早期进展至阿特珠单抗-贝伐珠单抗联合治疗的临床和影像评分系统
Jae Hyon Park,Myung Ji Goh,Dong Hyun Sinn et al.
Jae Hyon Park et al.
Objectives: To develop a predictive model incorporating both clinical and imaging findings to predict early progression in patients with advanced hepatocellular carcinoma (HCC) undergoing atezolizumab plus bevacizumab (At...